Proteome Sciences PLC PMSNF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.06
- Day Range
- $0.03–0.03
- 52-Week Range
- $0.03–0.09
- Bid/Ask
- $0.02 / $0.13
- Market Cap
- $9.51 Mil
- Volume/Avg
- 1,600 / 1,200
Key Statistics
- Price/Earnings (Normalized)
- 9.07
- Price/Sales
- 1.07
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Proteome Sciences PLC is protein biomarker research and development. The company uses high sensitivity proprietary techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications. Its only reportable segment is the sale of goods and biomarker services. It generates maximum revenue from the TMT product. Geographically, it has a presence in the United States, the United Kingdom, and the European Union.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 25
- Website
- https://www.proteomics.com
Valuation
|
Metric
|
PMSNF
|
|---|---|
Price/Earnings (Normalized) | 9.07 |
Price/Book Value | — |
Price/Sales | 1.07 |
Price/Cash Flow | 4.26 |
Price/Earnings
PMSNF
Financial Strength
|
Metric
|
PMSNF
|
|---|---|
Quick Ratio | 0.41 |
Current Ratio | 0.49 |
Interest Coverage | 1.95 |
Quick Ratio
PMSNF
Profitability
|
Metric
|
PMSNF
|
|---|---|
Return on Assets (Normalized) | 8.25% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | 14.82% |
Return on Assets
PMSNF
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Rwsgpfzypd | Nwdz | $208.9 Bil | |
DHR
| Danaher Corp | Bgczqqqkz | Zwjhc | $175.0 Bil | |
IQV
| IQVIA Holdings Inc | Kcpckfz | Zywzjj | $41.3 Bil | |
IDXX
| IDEXX Laboratories Inc | Mvqxbycmy | Zbzft | $39.7 Bil | |
A
| Agilent Technologies Inc | Llgmzkvyj | Ndt | $39.4 Bil | |
MTD
| Mettler-Toledo International Inc | Qcgpxwfzl | Mylywpj | $25.6 Bil | |
ICLR
| Icon PLC | Vklrzctfb | Kgxdtt | $24.1 Bil | |
ILMN
| Illumina Inc | Rykzkrs | Bwcnky | $18.6 Bil | |
WAT
| Waters Corp | Mdhctbqhng | Rfbk | $18.0 Bil | |
LH
| Laboratory Corp of America Holdings | Cnlltxbshx | Sxqxpt | $16.8 Bil |